• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用工程化脂质体靶向毒力因子磷脂酶C

Targeting the Virulence Factor Phospholipase C With Engineered Liposomes.

作者信息

Wolfmeier Heidi, Wardell Samuel J T, Liu Leo T, Falsafi Reza, Draeger Annette, Babiychuk Eduard B, Pletzer Daniel, Hancock Robert E W

机构信息

Department of Microbiology and Immunology, Centre for Microbial Diseases and Immunity Research, University of British Columbia, Vancouver, BC, Canada.

Institute of Anatomy and Cell Biology, Paracelsus Medical University, Salzburg, Austria.

出版信息

Front Microbiol. 2022 Mar 18;13:867449. doi: 10.3389/fmicb.2022.867449. eCollection 2022.

DOI:10.3389/fmicb.2022.867449
PMID:35369481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8971843/
Abstract

Engineered liposomes composed of the naturally occurring lipids sphingomyelin (Sm) and cholesterol (Ch) have been demonstrated to efficiently neutralize toxins secreted by Gram-positive bacteria such as and . Here, we hypothesized that liposomes are capable of neutralizing cytolytic virulence factors secreted by the Gram-negative pathogen . We used the highly virulent cystic fibrosis Liverpool Epidemic Strain LESB58 and showed that sphingomyelin (Sm) and a combination of sphingomyelin with cholesterol (Ch:Sm; 66 mol/% Ch and 34 mol/% Sm) liposomes reduced lysis of human bronchial and red blood cells upon challenge with the secretome. Mass spectrometry of liposome-sequestered proteins identified the virulence-promoting hemolytic phospholipase C (PlcH) as having been neutralized. supernatants incubated with liposomes demonstrated reduced PlcH activity as assessed by the -nitrophenylphosphorylcholine (NPPC) assay. Testing the efficacy of the liposomes in a murine cutaneous abscess model revealed that Sm and Ch:Sm, as single dose treatments, attenuated abscesses by >30%, demonstrating a similar effect to that of a mutant lacking in this infection model. Thus, sphingomyelin-containing liposome therapy offers an interesting approach to treat and reduce virulence of complex infections caused by and potentially other Gram-negative pathogens expressing .

摘要

由天然存在的脂质鞘磷脂(Sm)和胆固醇(Ch)组成的工程化脂质体已被证明能有效中和革兰氏阳性菌分泌的毒素,如……。在此,我们假设脂质体能够中和革兰氏阴性病原体分泌的细胞溶解性毒力因子。我们使用了高毒力的囊性纤维化利物浦流行菌株LESB58,结果表明,鞘磷脂(Sm)以及鞘磷脂与胆固醇的组合(Ch:Sm;66摩尔/% Ch和34摩尔/% Sm)脂质体在用该菌分泌组攻击后可减少人支气管细胞和红细胞的裂解。对脂质体隔离的该菌蛋白质进行质谱分析,确定毒力促进因子溶血磷脂酶C(PlcH)已被中和。通过对硝基苯基磷酰胆碱(NPPC)测定评估,与脂质体一起孵育的该菌培养上清液显示出降低的PlcH活性。在小鼠皮肤脓肿模型中测试脂质体的疗效,结果显示,作为单剂量治疗,Sm和Ch:Sm可使脓肿减轻>30%,在该感染模型中显示出与缺乏该菌的突变体类似的效果。因此,含鞘磷脂的脂质体疗法为治疗和降低由该菌以及可能表达该菌的其他革兰氏阴性病原体引起的复杂感染的毒力提供了一种有趣的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce5/8971843/d275714c6b45/fmicb-13-867449-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce5/8971843/b6d45cd9ef72/fmicb-13-867449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce5/8971843/158e74d21457/fmicb-13-867449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce5/8971843/d275714c6b45/fmicb-13-867449-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce5/8971843/b6d45cd9ef72/fmicb-13-867449-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce5/8971843/158e74d21457/fmicb-13-867449-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ce5/8971843/d275714c6b45/fmicb-13-867449-g003.jpg

相似文献

1
Targeting the Virulence Factor Phospholipase C With Engineered Liposomes.用工程化脂质体靶向毒力因子磷脂酶C
Front Microbiol. 2022 Mar 18;13:867449. doi: 10.3389/fmicb.2022.867449. eCollection 2022.
2
Purification, characterization, and identification of a sphingomyelin synthase from Pseudomonas aeruginosa. PlcH is a multifunctional enzyme.铜绿假单胞菌鞘磷脂合酶的纯化、表征及鉴定。PlcH是一种多功能酶。
J Biol Chem. 2003 Aug 29;278(35):32733-43. doi: 10.1074/jbc.M300932200. Epub 2003 Jun 10.
3
Liposomal Therapy Attenuates Dermonecrosis Induced by Community-Associated Methicillin-Resistant Staphylococcus aureus by Targeting α-Type Phenol-Soluble Modulins and α-Hemolysin.脂质体疗法通过靶向α-型酚溶性调节素和α-溶血素来减轻社区相关性耐甲氧西林金黄色葡萄球菌引起的皮肤坏死。
EBioMedicine. 2018 Jul;33:211-217. doi: 10.1016/j.ebiom.2018.06.016. Epub 2018 Jun 20.
4
Cooperation between LepA and PlcH contributes to the in vivo virulence and growth of Pseudomonas aeruginosa in mice.LepA 与 PlcH 的合作有助于铜绿假单胞菌在小鼠体内的毒力和生长。
Infect Immun. 2011 Jan;79(1):211-9. doi: 10.1128/IAI.01053-10. Epub 2010 Nov 1.
5
Sphingosine induction of the hemolytic phospholipase C/sphingomyelinase (PlcH).鞘氨醇诱导溶血磷脂酶 C/鞘磷脂酶(PlcH)。
J Bacteriol. 2024 Mar 21;206(3):e0038223. doi: 10.1128/jb.00382-23. Epub 2024 Feb 27.
6
New Mouse Model for Chronic Infections by Gram-Negative Bacteria Enabling the Study of Anti-Infective Efficacy and Host-Microbe Interactions.用于革兰氏阴性菌慢性感染的新型小鼠模型,可用于研究抗感染疗效和宿主-微生物相互作用。
mBio. 2017 Feb 28;8(1):e00140-17. doi: 10.1128/mBio.00140-17.
7
PlcR1 and PlcR2 are putative calcium-binding proteins required for secretion of the hemolytic phospholipase C of Pseudomonas aeruginosa.PlcR1和PlcR2是铜绿假单胞菌溶血磷脂酶C分泌所需的假定钙结合蛋白。
Infect Immun. 1997 Jul;65(7):2904-13. doi: 10.1128/iai.65.7.2904-2913.1997.
8
Ceramidase enhances phospholipase C-induced hemolysis by Pseudomonas aeruginosa.神经酰胺酶增强铜绿假单胞菌诱导的磷脂酶C介导的溶血作用。
J Biol Chem. 2007 Mar 2;282(9):6021-30. doi: 10.1074/jbc.M603088200. Epub 2007 Jan 3.
9
Global regulator Anr represses PlcH phospholipase activity in Pseudomonas aeruginosa when oxygen is limiting.全局调控因子Anr在氧气受限的情况下抑制铜绿假单胞菌中的PlcH磷脂酶活性。
Microbiology (Reading). 2014 Oct;160(Pt 10):2215-2225. doi: 10.1099/mic.0.081158-0. Epub 2014 Jul 29.
10
Identification of Novel Genomic Islands in Liverpool Epidemic Strain of Pseudomonas aeruginosa Using Segmentation and Clustering.利用分段和聚类方法鉴定铜绿假单胞菌利物浦流行菌株中的新型基因组岛
Front Microbiol. 2016 Aug 3;7:1210. doi: 10.3389/fmicb.2016.01210. eCollection 2016.

引用本文的文献

1
Potential Compounds as Inhibitors of Staphylococcal Virulence Factors Involved in the Development of Thrombosis.作为葡萄球菌毒力因子抑制剂的潜在化合物,这些毒力因子参与血栓形成过程。
Toxins (Basel). 2025 Jul 4;17(7):340. doi: 10.3390/toxins17070340.
2
Prevalence of different virulence factors and their association with antimicrobial resistance among Pseudomonas aeruginosa clinical isolates from Egypt.埃及临床分离的铜绿假单胞菌中不同毒力因子的流行情况及其与抗菌药物耐药性的关系。
BMC Microbiol. 2023 Jun 3;23(1):161. doi: 10.1186/s12866-023-02897-8.

本文引用的文献

1
Genome evolution drives transcriptomic and phenotypic adaptation in during 20 years of infection.基因组进化驱动 在 20 年感染期间的转录组和表型适应性。
Microb Genom. 2021 Nov;7(11). doi: 10.1099/mgen.0.000681.
2
Liposomes Prevent In Vitro Hemolysis Induced by Streptolysin O and Lysenin.脂质体可预防链球菌溶血素O和溶菌素诱导的体外溶血。
Membranes (Basel). 2021 May 18;11(5):364. doi: 10.3390/membranes11050364.
3
Carbapenem-Resistant Strains-Distribution of the Essential Enzymatic Virulence Factors Genes.耐碳青霉烯类菌株——关键酶促毒力因子基因的分布情况
Antibiotics (Basel). 2020 Dec 24;10(1):8. doi: 10.3390/antibiotics10010008.
4
Exploring Virulence Factors and Alternative Therapies against Pneumonia.探索肺炎的毒力因子和替代疗法。
Toxins (Basel). 2020 Nov 18;12(11):721. doi: 10.3390/toxins12110721.
5
Functional redundancy of Burkholderia pseudomallei phospholipase C enzymes and their role in virulence.伯克霍尔德氏菌磷脂酶 C 酶的功能冗余及其在毒力中的作用。
Sci Rep. 2020 Nov 6;10(1):19242. doi: 10.1038/s41598-020-76186-z.
6
The Stringent Stress Response Controls Proteases and Global Regulators under Optimal Growth Conditions in Pseudomonas aeruginosa.在铜绿假单胞菌的最佳生长条件下,严格应激反应控制蛋白酶和全局调节因子。
mSystems. 2020 Aug 4;5(4):e00495-20. doi: 10.1128/mSystems.00495-20.
7
Inhaled Liposomal Antimicrobial Delivery in Lung Infections.吸入型脂质体抗菌药物递药系统治疗肺部感染。
Drugs. 2020 Sep;80(13):1309-1318. doi: 10.1007/s40265-020-01359-z.
8
Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs.未来治疗细菌感染的可能药物:抗毒药物。
J Antibiot (Tokyo). 2021 Jan;74(1):24-41. doi: 10.1038/s41429-020-0344-z. Epub 2020 Jul 9.
9
Antivirulence compounds: a future direction to overcome antibiotic resistance?抗毒力化合物:克服抗生素耐药性的未来方向?
Future Microbiol. 2020 Mar;15:299-301. doi: 10.2217/fmb-2019-0294.
10
Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.战胜抗生素耐药菌:探索后抗生素时代的替代疗法。
Int J Mol Sci. 2020 Feb 5;21(3):1061. doi: 10.3390/ijms21031061.